Skip to Main Content

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer

Conditions

Breast - Female

Phase III

What is the purpose of this trial?

This randomized phase III trial studies whether weight loss in overweight and obese women may prevent breast cancer from coming back (recurrence). Previous studies have found that women who are overweight or obese when their breast cancer is found (diagnosed) have a greater risk of their breast cancer recurring, as compared to women who were thinner when their cancer was diagnosed. This study aims to test whether overweight or obese women who take part in a weight loss program after being diagnosed with breast cancer have a lower rate of cancer recurrence as compared to women who do not take part in the weight loss program. This study will help to show whether weight loss programs should be a part of breast cancer treatment.

  • Ages
    18 years and older
  • Gender
    Female only
  • Trial with
    Alliance Cooperative Group
  • Start Date
    10/19/2016
  • End Date
    05/30/2030
Trial Image

For more information about this study, contact:

Courtney Frederick

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    04/26/2018
  • Study HIC
    #1607018037